Anonymous
Guest
Anonymous
Guest
Based on this analysis, and when cross referencing market share and Victrellis sales volume, most of the patients who have been prescribed Victrelis have died.
Interesting trend emerging......as incivek sales dropped due to warehousing....well that started about 14 months ago.....but with the all oral still a long way away...some of those warehoused patients are running out of time and are coming back into category of needing treatment sooner.....which will bolster the sales of both incivek and victrelis.....